人福医药：近日收到《药品注册证书》

Group 1 - The core point of the article is that Junfeng Pharmaceutical has received approval for the injection of remimazolam benzenesulfonate from the National Medical Products Administration [1] - The company holds an 80% stake in its subsidiary, Yichang Junfeng Pharmaceutical Co., Ltd., which is responsible for the newly approved drug [1]